nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorescein—CYP1A1—kidney cancer	0.355	1	CbGaD
Fluorescein—ABCB11—Paclitaxel—kidney cancer	0.0738	0.141	CbGbCtD
Fluorescein—ABCC1—Dactinomycin—kidney cancer	0.0734	0.14	CbGbCtD
Fluorescein—ABCB11—Vinblastine—kidney cancer	0.0647	0.124	CbGbCtD
Fluorescein—ABCB11—Vincristine—kidney cancer	0.0636	0.122	CbGbCtD
Fluorescein—ABCC1—Paclitaxel—kidney cancer	0.0524	0.1	CbGbCtD
Fluorescein—ABCC1—Vinblastine—kidney cancer	0.046	0.088	CbGbCtD
Fluorescein—ABCC1—Vincristine—kidney cancer	0.0452	0.0865	CbGbCtD
Fluorescein—ABCB11—Doxorubicin—kidney cancer	0.0398	0.0761	CbGbCtD
Fluorescein—CYP1A1—Erlotinib—kidney cancer	0.0354	0.0677	CbGbCtD
Fluorescein—ABCC1—Doxorubicin—kidney cancer	0.0282	0.0541	CbGbCtD
Fluorescein—Dyspnoea—Sorafenib—kidney cancer	0.000192	0.00156	CcSEcCtD
Fluorescein—Abdominal pain—Erlotinib—kidney cancer	0.000189	0.00154	CcSEcCtD
Fluorescein—Ill-defined disorder—Gemcitabine—kidney cancer	0.000189	0.00154	CcSEcCtD
Fluorescein—Nausea—Pazopanib—kidney cancer	0.000187	0.00152	CcSEcCtD
Fluorescein—Neoplasm—Doxorubicin—kidney cancer	0.000187	0.00152	CcSEcCtD
Fluorescein—Paraesthesia—Sunitinib—kidney cancer	0.000186	0.00151	CcSEcCtD
Fluorescein—Convulsion—Vincristine—kidney cancer	0.000186	0.00151	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000186	0.00151	CcSEcCtD
Fluorescein—Hypertension—Vincristine—kidney cancer	0.000186	0.00151	CcSEcCtD
Fluorescein—Dyspnoea—Sunitinib—kidney cancer	0.000185	0.0015	CcSEcCtD
Fluorescein—Pain—Sorafenib—kidney cancer	0.000184	0.0015	CcSEcCtD
Fluorescein—Malaise—Gemcitabine—kidney cancer	0.000184	0.00149	CcSEcCtD
Fluorescein—Pulmonary oedema—Doxorubicin—kidney cancer	0.000184	0.00149	CcSEcCtD
Fluorescein—Hypersensitivity—Vinblastine—kidney cancer	0.000184	0.00149	CcSEcCtD
Fluorescein—Hypersensitivity—Everolimus—kidney cancer	0.000183	0.00149	CcSEcCtD
Fluorescein—Cardiac disorder—Paclitaxel—kidney cancer	0.000182	0.00148	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000179	0.00146	CcSEcCtD
Fluorescein—Asthenia—Vinblastine—kidney cancer	0.000179	0.00145	CcSEcCtD
Fluorescein—Asthenia—Everolimus—kidney cancer	0.000178	0.00145	CcSEcCtD
Fluorescein—Cough—Gemcitabine—kidney cancer	0.000178	0.00145	CcSEcCtD
Fluorescein—Angiopathy—Paclitaxel—kidney cancer	0.000178	0.00145	CcSEcCtD
Fluorescein—Pain—Sunitinib—kidney cancer	0.000177	0.00144	CcSEcCtD
Fluorescein—Immune system disorder—Paclitaxel—kidney cancer	0.000177	0.00144	CcSEcCtD
Fluorescein—Mediastinal disorder—Paclitaxel—kidney cancer	0.000177	0.00144	CcSEcCtD
Fluorescein—Gastrointestinal pain—Sorafenib—kidney cancer	0.000176	0.00143	CcSEcCtD
Fluorescein—Hypertension—Gemcitabine—kidney cancer	0.000176	0.00143	CcSEcCtD
Fluorescein—Chills—Paclitaxel—kidney cancer	0.000176	0.00143	CcSEcCtD
Fluorescein—Pruritus—Everolimus—kidney cancer	0.000176	0.00143	CcSEcCtD
Fluorescein—Oedema—Vincristine—kidney cancer	0.000175	0.00143	CcSEcCtD
Fluorescein—Anaphylactic shock—Vincristine—kidney cancer	0.000175	0.00143	CcSEcCtD
Fluorescein—Chest pain—Gemcitabine—kidney cancer	0.000174	0.00141	CcSEcCtD
Fluorescein—Thrombophlebitis—Doxorubicin—kidney cancer	0.000173	0.00141	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000172	0.0014	CcSEcCtD
Fluorescein—Nervous system disorder—Vincristine—kidney cancer	0.000172	0.0014	CcSEcCtD
Fluorescein—Asthenia—Erlotinib—kidney cancer	0.000172	0.0014	CcSEcCtD
Fluorescein—Discomfort—Gemcitabine—kidney cancer	0.000172	0.00139	CcSEcCtD
Fluorescein—Urticaria—Sorafenib—kidney cancer	0.000171	0.00139	CcSEcCtD
Fluorescein—Erythema—Paclitaxel—kidney cancer	0.000171	0.00139	CcSEcCtD
Fluorescein—Abdominal pain—Sorafenib—kidney cancer	0.00017	0.00139	CcSEcCtD
Fluorescein—Gastrointestinal pain—Sunitinib—kidney cancer	0.00017	0.00138	CcSEcCtD
Fluorescein—Hyperhidrosis—Vincristine—kidney cancer	0.00017	0.00138	CcSEcCtD
Fluorescein—Pruritus—Erlotinib—kidney cancer	0.00017	0.00138	CcSEcCtD
Fluorescein—Pain—Dactinomycin—kidney cancer	0.000168	0.00137	CcSEcCtD
Fluorescein—Dysgeusia—Paclitaxel—kidney cancer	0.000167	0.00136	CcSEcCtD
Fluorescein—Eczema—Doxorubicin—kidney cancer	0.000167	0.00136	CcSEcCtD
Fluorescein—Anaphylactic shock—Gemcitabine—kidney cancer	0.000166	0.00135	CcSEcCtD
Fluorescein—Oedema—Gemcitabine—kidney cancer	0.000166	0.00135	CcSEcCtD
Fluorescein—Dizziness—Vinblastine—kidney cancer	0.000165	0.00134	CcSEcCtD
Fluorescein—Dizziness—Everolimus—kidney cancer	0.000164	0.00133	CcSEcCtD
Fluorescein—Abdominal pain—Sunitinib—kidney cancer	0.000164	0.00133	CcSEcCtD
Fluorescein—Hypotension—Vincristine—kidney cancer	0.000164	0.00133	CcSEcCtD
Fluorescein—Bradycardia—Capecitabine—kidney cancer	0.000164	0.00133	CcSEcCtD
Fluorescein—Nervous system disorder—Gemcitabine—kidney cancer	0.000163	0.00133	CcSEcCtD
Fluorescein—Feeling abnormal—Dactinomycin—kidney cancer	0.000162	0.00132	CcSEcCtD
Fluorescein—Skin disorder—Gemcitabine—kidney cancer	0.000162	0.00131	CcSEcCtD
Fluorescein—Hyperhidrosis—Gemcitabine—kidney cancer	0.000161	0.00131	CcSEcCtD
Fluorescein—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000161	0.00131	CcSEcCtD
Fluorescein—Hot flush—Doxorubicin—kidney cancer	0.00016	0.0013	CcSEcCtD
Fluorescein—Hypoaesthesia—Capecitabine—kidney cancer	0.00016	0.0013	CcSEcCtD
Fluorescein—Tremor—Paclitaxel—kidney cancer	0.00016	0.0013	CcSEcCtD
Fluorescein—Menopausal symptoms—Doxorubicin—kidney cancer	0.000159	0.00129	CcSEcCtD
Fluorescein—Hypersensitivity—Sorafenib—kidney cancer	0.000159	0.00129	CcSEcCtD
Fluorescein—Vomiting—Vinblastine—kidney cancer	0.000158	0.00129	CcSEcCtD
Fluorescein—Dizziness—Erlotinib—kidney cancer	0.000158	0.00129	CcSEcCtD
Fluorescein—Ill-defined disorder—Paclitaxel—kidney cancer	0.000158	0.00129	CcSEcCtD
Fluorescein—Vomiting—Everolimus—kidney cancer	0.000158	0.00128	CcSEcCtD
Fluorescein—Paraesthesia—Vincristine—kidney cancer	0.000158	0.00128	CcSEcCtD
Fluorescein—Rash—Everolimus—kidney cancer	0.000157	0.00127	CcSEcCtD
Fluorescein—Dermatitis—Everolimus—kidney cancer	0.000156	0.00127	CcSEcCtD
Fluorescein—Headache—Vinblastine—kidney cancer	0.000156	0.00127	CcSEcCtD
Fluorescein—Headache—Everolimus—kidney cancer	0.000156	0.00126	CcSEcCtD
Fluorescein—Hypotension—Gemcitabine—kidney cancer	0.000156	0.00126	CcSEcCtD
Fluorescein—Abdominal pain—Dactinomycin—kidney cancer	0.000155	0.00126	CcSEcCtD
Fluorescein—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000155	0.00126	CcSEcCtD
Fluorescein—Asthenia—Sorafenib—kidney cancer	0.000155	0.00126	CcSEcCtD
Fluorescein—Malaise—Paclitaxel—kidney cancer	0.000154	0.00125	CcSEcCtD
Fluorescein—Syncope—Paclitaxel—kidney cancer	0.000153	0.00124	CcSEcCtD
Fluorescein—Cerebrovascular accident—Doxorubicin—kidney cancer	0.000153	0.00124	CcSEcCtD
Fluorescein—Hypersensitivity—Sunitinib—kidney cancer	0.000153	0.00124	CcSEcCtD
Fluorescein—Pruritus—Sorafenib—kidney cancer	0.000153	0.00124	CcSEcCtD
Fluorescein—Vomiting—Erlotinib—kidney cancer	0.000152	0.00124	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Vincristine—kidney cancer	0.000151	0.00123	CcSEcCtD
Fluorescein—Rash—Erlotinib—kidney cancer	0.000151	0.00123	CcSEcCtD
Fluorescein—Dermatitis—Erlotinib—kidney cancer	0.000151	0.00123	CcSEcCtD
Fluorescein—Headache—Erlotinib—kidney cancer	0.00015	0.00122	CcSEcCtD
Fluorescein—Loss of consciousness—Paclitaxel—kidney cancer	0.00015	0.00122	CcSEcCtD
Fluorescein—Pain—Vincristine—kidney cancer	0.00015	0.00122	CcSEcCtD
Fluorescein—Paraesthesia—Gemcitabine—kidney cancer	0.000149	0.00121	CcSEcCtD
Fluorescein—Cardiac disorder—Capecitabine—kidney cancer	0.000149	0.00121	CcSEcCtD
Fluorescein—Cough—Paclitaxel—kidney cancer	0.000149	0.00121	CcSEcCtD
Fluorescein—Asthenia—Sunitinib—kidney cancer	0.000149	0.00121	CcSEcCtD
Fluorescein—Dyspnoea—Gemcitabine—kidney cancer	0.000148	0.00121	CcSEcCtD
Fluorescein—Nausea—Vinblastine—kidney cancer	0.000148	0.0012	CcSEcCtD
Fluorescein—Convulsion—Paclitaxel—kidney cancer	0.000148	0.0012	CcSEcCtD
Fluorescein—Nausea—Everolimus—kidney cancer	0.000147	0.0012	CcSEcCtD
Fluorescein—Hypertension—Paclitaxel—kidney cancer	0.000147	0.0012	CcSEcCtD
Fluorescein—Pruritus—Sunitinib—kidney cancer	0.000147	0.00119	CcSEcCtD
Fluorescein—Angiopathy—Capecitabine—kidney cancer	0.000146	0.00119	CcSEcCtD
Fluorescein—Immune system disorder—Capecitabine—kidney cancer	0.000145	0.00118	CcSEcCtD
Fluorescein—Chest pain—Paclitaxel—kidney cancer	0.000145	0.00118	CcSEcCtD
Fluorescein—Mediastinal disorder—Capecitabine—kidney cancer	0.000145	0.00118	CcSEcCtD
Fluorescein—Hypersensitivity—Dactinomycin—kidney cancer	0.000145	0.00118	CcSEcCtD
Fluorescein—Chills—Capecitabine—kidney cancer	0.000144	0.00117	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000144	0.00117	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000144	0.00117	CcSEcCtD
Fluorescein—Discomfort—Paclitaxel—kidney cancer	0.000144	0.00117	CcSEcCtD
Fluorescein—Gastrointestinal pain—Vincristine—kidney cancer	0.000143	0.00117	CcSEcCtD
Fluorescein—Cardiac arrest—Doxorubicin—kidney cancer	0.000143	0.00116	CcSEcCtD
Fluorescein—Dizziness—Sorafenib—kidney cancer	0.000143	0.00116	CcSEcCtD
Fluorescein—Pain—Gemcitabine—kidney cancer	0.000142	0.00116	CcSEcCtD
Fluorescein—Nausea—Erlotinib—kidney cancer	0.000142	0.00116	CcSEcCtD
Fluorescein—Asthenia—Dactinomycin—kidney cancer	0.000141	0.00115	CcSEcCtD
Fluorescein—Erythema—Capecitabine—kidney cancer	0.00014	0.00114	CcSEcCtD
Fluorescein—Anaphylactic shock—Paclitaxel—kidney cancer	0.000139	0.00113	CcSEcCtD
Fluorescein—Oedema—Paclitaxel—kidney cancer	0.000139	0.00113	CcSEcCtD
Fluorescein—Abdominal pain—Vincristine—kidney cancer	0.000139	0.00113	CcSEcCtD
Fluorescein—Dysgeusia—Capecitabine—kidney cancer	0.000137	0.00112	CcSEcCtD
Fluorescein—Dizziness—Sunitinib—kidney cancer	0.000137	0.00112	CcSEcCtD
Fluorescein—Feeling abnormal—Gemcitabine—kidney cancer	0.000137	0.00111	CcSEcCtD
Fluorescein—Shock—Paclitaxel—kidney cancer	0.000137	0.00111	CcSEcCtD
Fluorescein—Vomiting—Sorafenib—kidney cancer	0.000137	0.00111	CcSEcCtD
Fluorescein—Nervous system disorder—Paclitaxel—kidney cancer	0.000137	0.00111	CcSEcCtD
Fluorescein—Tachycardia—Paclitaxel—kidney cancer	0.000136	0.00111	CcSEcCtD
Fluorescein—Rash—Sorafenib—kidney cancer	0.000136	0.0011	CcSEcCtD
Fluorescein—Dermatitis—Sorafenib—kidney cancer	0.000136	0.0011	CcSEcCtD
Fluorescein—Skin disorder—Paclitaxel—kidney cancer	0.000135	0.0011	CcSEcCtD
Fluorescein—Headache—Sorafenib—kidney cancer	0.000135	0.0011	CcSEcCtD
Fluorescein—Hyperhidrosis—Paclitaxel—kidney cancer	0.000135	0.0011	CcSEcCtD
Fluorescein—Vomiting—Sunitinib—kidney cancer	0.000132	0.00107	CcSEcCtD
Fluorescein—Tremor—Capecitabine—kidney cancer	0.000131	0.00107	CcSEcCtD
Fluorescein—Rash—Sunitinib—kidney cancer	0.000131	0.00106	CcSEcCtD
Fluorescein—Dermatitis—Sunitinib—kidney cancer	0.000131	0.00106	CcSEcCtD
Fluorescein—Hypotension—Paclitaxel—kidney cancer	0.00013	0.00106	CcSEcCtD
Fluorescein—Ill-defined disorder—Capecitabine—kidney cancer	0.00013	0.00106	CcSEcCtD
Fluorescein—Headache—Sunitinib—kidney cancer	0.00013	0.00106	CcSEcCtD
Fluorescein—Asthma—Doxorubicin—kidney cancer	0.00013	0.00105	CcSEcCtD
Fluorescein—Hypersensitivity—Vincristine—kidney cancer	0.000129	0.00105	CcSEcCtD
Fluorescein—Nausea—Sorafenib—kidney cancer	0.000128	0.00104	CcSEcCtD
Fluorescein—Malaise—Capecitabine—kidney cancer	0.000126	0.00103	CcSEcCtD
Fluorescein—Angina pectoris—Doxorubicin—kidney cancer	0.000126	0.00103	CcSEcCtD
Fluorescein—Asthenia—Vincristine—kidney cancer	0.000126	0.00102	CcSEcCtD
Fluorescein—Syncope—Capecitabine—kidney cancer	0.000126	0.00102	CcSEcCtD
Fluorescein—Paraesthesia—Paclitaxel—kidney cancer	0.000125	0.00102	CcSEcCtD
Fluorescein—Vomiting—Dactinomycin—kidney cancer	0.000125	0.00101	CcSEcCtD
Fluorescein—Dyspnoea—Paclitaxel—kidney cancer	0.000124	0.00101	CcSEcCtD
Fluorescein—Rash—Dactinomycin—kidney cancer	0.000124	0.00101	CcSEcCtD
Fluorescein—Nausea—Sunitinib—kidney cancer	0.000123	0.001	CcSEcCtD
Fluorescein—Loss of consciousness—Capecitabine—kidney cancer	0.000123	0.001	CcSEcCtD
Fluorescein—Cough—Capecitabine—kidney cancer	0.000122	0.000994	CcSEcCtD
Fluorescein—Hypertension—Capecitabine—kidney cancer	0.000121	0.000983	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.00012	0.000978	CcSEcCtD
Fluorescein—Asthenia—Gemcitabine—kidney cancer	0.000119	0.000971	CcSEcCtD
Fluorescein—Chest pain—Capecitabine—kidney cancer	0.000119	0.00097	CcSEcCtD
Fluorescein—Pain—Paclitaxel—kidney cancer	0.000119	0.000969	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000118	0.000963	CcSEcCtD
Fluorescein—Discomfort—Capecitabine—kidney cancer	0.000118	0.000958	CcSEcCtD
Fluorescein—Pruritus—Gemcitabine—kidney cancer	0.000118	0.000957	CcSEcCtD
Fluorescein—Nausea—Dactinomycin—kidney cancer	0.000117	0.000948	CcSEcCtD
Fluorescein—Dizziness—Vincristine—kidney cancer	0.000116	0.000943	CcSEcCtD
Fluorescein—Feeling abnormal—Paclitaxel—kidney cancer	0.000115	0.000933	CcSEcCtD
Fluorescein—Oedema—Capecitabine—kidney cancer	0.000114	0.00093	CcSEcCtD
Fluorescein—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000114	0.000926	CcSEcCtD
Fluorescein—Shock—Capecitabine—kidney cancer	0.000112	0.000915	CcSEcCtD
Fluorescein—Nervous system disorder—Capecitabine—kidney cancer	0.000112	0.000912	CcSEcCtD
Fluorescein—Tachycardia—Capecitabine—kidney cancer	0.000112	0.000907	CcSEcCtD
Fluorescein—Vomiting—Vincristine—kidney cancer	0.000112	0.000907	CcSEcCtD
Fluorescein—Skin disorder—Capecitabine—kidney cancer	0.000111	0.000903	CcSEcCtD
Fluorescein—Urticaria—Paclitaxel—kidney cancer	0.000111	0.0009	CcSEcCtD
Fluorescein—Rash—Vincristine—kidney cancer	0.000111	0.000899	CcSEcCtD
Fluorescein—Hyperhidrosis—Capecitabine—kidney cancer	0.000111	0.000899	CcSEcCtD
Fluorescein—Dermatitis—Vincristine—kidney cancer	0.000111	0.000898	CcSEcCtD
Fluorescein—Abdominal pain—Paclitaxel—kidney cancer	0.00011	0.000895	CcSEcCtD
Fluorescein—Headache—Vincristine—kidney cancer	0.00011	0.000893	CcSEcCtD
Fluorescein—Hypotension—Capecitabine—kidney cancer	0.000107	0.000869	CcSEcCtD
Fluorescein—Vomiting—Gemcitabine—kidney cancer	0.000106	0.00086	CcSEcCtD
Fluorescein—Bradycardia—Doxorubicin—kidney cancer	0.000106	0.000859	CcSEcCtD
Fluorescein—Rash—Gemcitabine—kidney cancer	0.000105	0.000853	CcSEcCtD
Fluorescein—Dermatitis—Gemcitabine—kidney cancer	0.000105	0.000852	CcSEcCtD
Fluorescein—Headache—Gemcitabine—kidney cancer	0.000104	0.000848	CcSEcCtD
Fluorescein—Nausea—Vincristine—kidney cancer	0.000104	0.000847	CcSEcCtD
Fluorescein—Hypoaesthesia—Doxorubicin—kidney cancer	0.000103	0.000839	CcSEcCtD
Fluorescein—Paraesthesia—Capecitabine—kidney cancer	0.000103	0.000835	CcSEcCtD
Fluorescein—Hypersensitivity—Paclitaxel—kidney cancer	0.000103	0.000835	CcSEcCtD
Fluorescein—Dyspnoea—Capecitabine—kidney cancer	0.000102	0.000829	CcSEcCtD
Fluorescein—Asthenia—Paclitaxel—kidney cancer	0.0001	0.000813	CcSEcCtD
Fluorescein—Nausea—Gemcitabine—kidney cancer	9.89e-05	0.000804	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Capecitabine—kidney cancer	9.87e-05	0.000803	CcSEcCtD
Fluorescein—Pruritus—Paclitaxel—kidney cancer	9.86e-05	0.000801	CcSEcCtD
Fluorescein—Pain—Capecitabine—kidney cancer	9.78e-05	0.000795	CcSEcCtD
Fluorescein—Cardiac disorder—Doxorubicin—kidney cancer	9.63e-05	0.000783	CcSEcCtD
Fluorescein—Feeling abnormal—Capecitabine—kidney cancer	9.42e-05	0.000766	CcSEcCtD
Fluorescein—Angiopathy—Doxorubicin—kidney cancer	9.41e-05	0.000765	CcSEcCtD
Fluorescein—Immune system disorder—Doxorubicin—kidney cancer	9.37e-05	0.000762	CcSEcCtD
Fluorescein—Gastrointestinal pain—Capecitabine—kidney cancer	9.35e-05	0.00076	CcSEcCtD
Fluorescein—Mediastinal disorder—Doxorubicin—kidney cancer	9.35e-05	0.00076	CcSEcCtD
Fluorescein—Chills—Doxorubicin—kidney cancer	9.31e-05	0.000757	CcSEcCtD
Fluorescein—Dizziness—Paclitaxel—kidney cancer	9.21e-05	0.000749	CcSEcCtD
Fluorescein—Urticaria—Capecitabine—kidney cancer	9.08e-05	0.000738	CcSEcCtD
Fluorescein—Abdominal pain—Capecitabine—kidney cancer	9.04e-05	0.000735	CcSEcCtD
Fluorescein—Erythema—Doxorubicin—kidney cancer	9.03e-05	0.000734	CcSEcCtD
Fluorescein—Vomiting—Paclitaxel—kidney cancer	8.86e-05	0.00072	CcSEcCtD
Fluorescein—Dysgeusia—Doxorubicin—kidney cancer	8.84e-05	0.000719	CcSEcCtD
Fluorescein—Rash—Paclitaxel—kidney cancer	8.79e-05	0.000714	CcSEcCtD
Fluorescein—Dermatitis—Paclitaxel—kidney cancer	8.78e-05	0.000714	CcSEcCtD
Fluorescein—Headache—Paclitaxel—kidney cancer	8.73e-05	0.00071	CcSEcCtD
Fluorescein—Hypersensitivity—Capecitabine—kidney cancer	8.42e-05	0.000685	CcSEcCtD
Fluorescein—Ill-defined disorder—Doxorubicin—kidney cancer	8.38e-05	0.000681	CcSEcCtD
Fluorescein—Nausea—Paclitaxel—kidney cancer	8.28e-05	0.000673	CcSEcCtD
Fluorescein—Asthenia—Capecitabine—kidney cancer	8.2e-05	0.000667	CcSEcCtD
Fluorescein—Malaise—Doxorubicin—kidney cancer	8.14e-05	0.000662	CcSEcCtD
Fluorescein—Syncope—Doxorubicin—kidney cancer	8.1e-05	0.000658	CcSEcCtD
Fluorescein—Pruritus—Capecitabine—kidney cancer	8.09e-05	0.000658	CcSEcCtD
Fluorescein—Loss of consciousness—Doxorubicin—kidney cancer	7.94e-05	0.000645	CcSEcCtD
Fluorescein—Cough—Doxorubicin—kidney cancer	7.88e-05	0.000641	CcSEcCtD
Fluorescein—Convulsion—Doxorubicin—kidney cancer	7.82e-05	0.000636	CcSEcCtD
Fluorescein—Hypertension—Doxorubicin—kidney cancer	7.8e-05	0.000634	CcSEcCtD
Fluorescein—Chest pain—Doxorubicin—kidney cancer	7.69e-05	0.000625	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	7.64e-05	0.000621	CcSEcCtD
Fluorescein—Discomfort—Doxorubicin—kidney cancer	7.6e-05	0.000618	CcSEcCtD
Fluorescein—Dizziness—Capecitabine—kidney cancer	7.56e-05	0.000615	CcSEcCtD
Fluorescein—Oedema—Doxorubicin—kidney cancer	7.37e-05	0.000599	CcSEcCtD
Fluorescein—Anaphylactic shock—Doxorubicin—kidney cancer	7.37e-05	0.000599	CcSEcCtD
Fluorescein—Vomiting—Capecitabine—kidney cancer	7.27e-05	0.000591	CcSEcCtD
Fluorescein—Shock—Doxorubicin—kidney cancer	7.25e-05	0.00059	CcSEcCtD
Fluorescein—Nervous system disorder—Doxorubicin—kidney cancer	7.23e-05	0.000588	CcSEcCtD
Fluorescein—Rash—Capecitabine—kidney cancer	7.21e-05	0.000586	CcSEcCtD
Fluorescein—Dermatitis—Capecitabine—kidney cancer	7.2e-05	0.000586	CcSEcCtD
Fluorescein—Tachycardia—Doxorubicin—kidney cancer	7.19e-05	0.000585	CcSEcCtD
Fluorescein—Headache—Capecitabine—kidney cancer	7.16e-05	0.000582	CcSEcCtD
Fluorescein—Skin disorder—Doxorubicin—kidney cancer	7.16e-05	0.000582	CcSEcCtD
Fluorescein—Hyperhidrosis—Doxorubicin—kidney cancer	7.13e-05	0.000579	CcSEcCtD
Fluorescein—Hypotension—Doxorubicin—kidney cancer	6.89e-05	0.00056	CcSEcCtD
Fluorescein—Nausea—Capecitabine—kidney cancer	6.79e-05	0.000552	CcSEcCtD
Fluorescein—Paraesthesia—Doxorubicin—kidney cancer	6.62e-05	0.000538	CcSEcCtD
Fluorescein—Dyspnoea—Doxorubicin—kidney cancer	6.57e-05	0.000534	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Doxorubicin—kidney cancer	6.36e-05	0.000517	CcSEcCtD
Fluorescein—Pain—Doxorubicin—kidney cancer	6.3e-05	0.000512	CcSEcCtD
Fluorescein—Feeling abnormal—Doxorubicin—kidney cancer	6.07e-05	0.000494	CcSEcCtD
Fluorescein—Gastrointestinal pain—Doxorubicin—kidney cancer	6.03e-05	0.00049	CcSEcCtD
Fluorescein—Urticaria—Doxorubicin—kidney cancer	5.86e-05	0.000476	CcSEcCtD
Fluorescein—Abdominal pain—Doxorubicin—kidney cancer	5.83e-05	0.000474	CcSEcCtD
Fluorescein—Hypersensitivity—Doxorubicin—kidney cancer	5.43e-05	0.000441	CcSEcCtD
Fluorescein—Asthenia—Doxorubicin—kidney cancer	5.29e-05	0.00043	CcSEcCtD
Fluorescein—Pruritus—Doxorubicin—kidney cancer	5.21e-05	0.000424	CcSEcCtD
Fluorescein—Dizziness—Doxorubicin—kidney cancer	4.87e-05	0.000396	CcSEcCtD
Fluorescein—Vomiting—Doxorubicin—kidney cancer	4.69e-05	0.000381	CcSEcCtD
Fluorescein—Rash—Doxorubicin—kidney cancer	4.65e-05	0.000378	CcSEcCtD
Fluorescein—Dermatitis—Doxorubicin—kidney cancer	4.64e-05	0.000377	CcSEcCtD
Fluorescein—Headache—Doxorubicin—kidney cancer	4.62e-05	0.000375	CcSEcCtD
Fluorescein—Nausea—Doxorubicin—kidney cancer	4.38e-05	0.000356	CcSEcCtD
